

No data available
No data available
No data available
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 706.30 | 580.98 | 470.43 | 537.63 | 396.22 |
| Total Expenses | 457.82 | 415.29 | 346.94 | 330.38 | 228.91 |
| Profit Before Tax | 248.48 | 165.69 | 123.49 | 207.25 | 167.31 |
| Profit After Tax | 187.96 | 119.11 | 89.86 | 151.81 | 123.59 |
| Operating Profit After Depreciation | 250.17 | 167.80 | 126.57 | 211.44 | 171.39 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 452.87 | 310.13 | 261.54 | 189.77 | 100.04 |
| Total Non Current Assets | 675.28 | 523.43 | 355.39 | 237.22 | 180 |
| Total Current Assets | 437.04 | 398.01 | 464.89 | 497.54 | 265.46 |
| Total Assets | 1,112.31 | 921.45 | 820.28 | 734.76 | 445.47 |
| Total Shareholder's Fund | 996.76 | 815.37 | 699.46 | 615.69 | 268.58 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 164.68 | 113.31 | 63.61 | 48.80 | 75.89 |
| Net Cash Used In Investing Activities | -152.24 | -173.57 | -123.65 | -59.82 | -46.80 |
| Net Cash Used In Financing Activities | -8.23 | -22.36 | -10.28 | 149.65 | -14.52 |
No data available
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 276.53 | 206.44 | 199.83 | 145.07 | 184.11 |
| Total Expenses | 178.91 | 134.36 | 127.19 | 93.37 | 116.53 |
| Profit Before Tax | 92.13 | 66.92 | 68.31 | 47.41 | 64.06 |
| Profit After Tax | 74.23 | 49.68 | 50.43 | 34.79 | 50.38 |
| Operating Profit after Depreciation | 101.10 | 74.69 | 75.37 | 54.37 | 70.56 |
₹1.0/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
| Fund Name | AUM |
|---|---|
| Quantum Small Cap Fund | 4.60% |
| ITI Large & Mid Cap Fund | 1.73% |
| ITI ELSS Tax Saver Fund | 1.47% |
| Abakkus Flexi Cap Fund | 1.13% |
| ITI Pharma and Healthcare Fund | 0.77% |
Wockhardt Ltd, NHPC Ltd, Force Motors Ltd and RHI Magnesita India Ltd are among the other losers in the BSE's 'A' group today, 02 June 2026.
02 Jun 2026, 03:00 pm
Relaxo Footwears Ltd, Wockhardt Ltd, Netweb Technologies India Ltd and Ashapura Minechem Ltd are among the other gainers in the BSE's 'A' group today, 29 May 2026.
29 May 2026, 12:00 pm
Supriya Lifescience surged 18.06% to Rs 953.05 after the active pharmaceutical ingredients (API) manufacturer reported strong Q4 FY26 earnings.
29 May 2026, 10:26 am
Of Rs 1 per share
28 May 2026, 02:25 pm
On 27 May 2026
22 May 2026, 09:41 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.